🚨 BREAKTHROUGH IN NIPAH VIRUS RESEARCH 🚨 Virongy Biosciences is proud to announce the development of Ha-NiV, the most advanced Nipah pseudovirus to date, revolutionizing how we study this deadly pathogen. 🔬 What makes Ha-NiV groundbreaking? ✅ Highly Accurate – Mimics authentic Nipah virus structure for superior assay performance ✅ Rapid & Efficient – Enables fast neutralization testing and antiviral screening ✅ Safe & Scalable – A powerful tool for vaccine and therapeutic development With Nipah virus designated as a WHO priority pathogen due to its high mortality rate and pandemic potential, Ha-NiV provides researchers with a crucial platform to accelerate diagnostics, vaccines, and antiviral discovery. This work wouldn’t have been possible without the invaluable support of CEPI and Boston University, whose contributions helped bring this technology to life. Virongy Biosciences proudly holds the intellectual property for this cutting-edge system, reinforcing our mission to drive innovation in virology and global health. 📢 Scientists and biotech leaders—let’s collaborate to fight emerging viral threats! Contact us to learn how Ha-NiV can support your research. Check out the recent publication here: https://lnkd.in/eVW_Rnak #Virongy #NipahVirus #Pseudovirus #VaccineDevelopment #GlobalHealth #Virology #CEPI #BostonUniversity
Virongy Biosciences, Inc.
Biotechnology Research
Manassas, Virginia 291 followers
Virongy focuses on creating cutting-edge technologies in virology.
About us
Accelerating discovery through innovative platforms with elegantly simple workflows.
- Website
-
https://virongy.com/
External link for Virongy Biosciences, Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Manassas, Virginia
- Type
- Privately Held
- Founded
- 2013
- Specialties
- biotech, neutralizing antibody assays, Vaccine Efficacy Research, and Pseudovirus
Locations
-
Primary
11225 Assett Loop
STE 111
Manassas, Virginia 20109, US
Employees at Virongy Biosciences, Inc.
Updates
-
Just recently, we released our Lentiviral Vector Customization Tool ✂️🧬🦠! What are the advantages of using our tool, you ask? There are many: 1. You can create made-to-order 📦 lentiviral vectors that are delivered right to your doorstep 🚪 2. You're able to choose anywhere from 1 to 4 open reading frames for your vector. 3. You have the option to choose your own promoter ➡️, open reading frame(s), and selection marker. 4. If you don't need something so customized, you can choose components from our extensive database 📚 5. Scientists at Virongy will review the specifics of the vector to make sure we can provide you what you're looking for and will keep in contact with you throughout the process 👩🔬👨🔬 Want the vector turned into a plasmid? We can do that too! 🦠 Jump-start your custom lentiviral vector journey today: https://lnkd.in/g_zuux9C #Lentivirus #CustomVector #Science #Viruses #Innovation
-
🌠🚨PRODUCT LAUNCH🚨🌠 In light of the ever-intensifying situation with Highly Pathogenic Avian Influenza A (HPAI H5N1), the scientists at Virongy Biosciences, Inc. have developed an HPAI H5N1 clade 2.3.4.4b pseudovirus 🧬🦠 modeled after an isolate taken from the Texas dairy farm worker 🐄 who became infected with the virus in late March. HPAI H5N1 viruses have been on the CDC's watchlist for a while now. They are particularly dangerous because they have the capability to spread from mammal-to-mammal 🐄➡️🐈. HPAI H5N1 clade 2.3.4.4b first entered the Northern Hemisphere in 2021. When it spread, it spread fast and hard. Officially classified as an outbreak, a recent article released by the CDC describes how the virus has turned fatal for cats who are drinking unpasteurized milk 🥛 from infected cows. The article also warns about how HPAI viruses have pandemic potential🌎 Already, three dairy cattle workers have been infected in the United States - two in Michigan and one in Texas. Though their symptoms have been mild and each has since recovered, the deadly potential of these viruses have been displayed in countries like Ecuador and Chile where humans have contracted HPAI H5N1 clade 2.3.4.4b and become seriously ill 🤒 Together, we can prevent the HPAI H5N1 pandemic before it happens. Our Hybrid-Alpha HPAI H5N1 clade 2.3.4.4b Pseudoviral Neutralization Assay Kit serves as a platform for quick, easy, and reliable quantification of neutralizing antibodies, viral variants, and antiviral drugs 💊 Help us protect both humans and animals alike from HPAI H5N1 before the situation becomes out-of-hand 🛡️ Learn more about HPAI H5N1 clade 2.3.4.4b by visiting this article released by the CDC: https://lnkd.in/gNXnAzVE Visit our product page to learn more about our new Hybrid-Alpha HPAI H5N1 clade 2.3.4.4b Pseudoviral Neutralization Assay Kit: https://lnkd.in/e6divRkB #H5N1 #AvianInfluenza #ProductLaunch #Virology #Science
-
🚨📰BREAKING NEWS!!!🚨📰 Yesterday, May 30th, the Centers for Disease Control and Prevention (CDC) released a statement confirming the THIRD case of H5 Bird Flu in a human in the United States 😮 This is now the second highly pathogenic avian influenza (HPAI) case in the state of Michigan. Like the other two cases in Michigan and Texas, the individual works on a dairy farm and was exposed to infected cows 🦠🐄 Thus far, the CDC has found one major difference between this case and the previous two: the person who contracted HPAI DID display symptoms of an upper respiratory infection. These included: ➡️ Cough 😮💨 ➡️ Eye watering 💧 ➡️ Eye discomfort 👁️ The patient was given oseltamivir, an antiviral treatment for influenza viruses, and is recovering well 🏥 Now the question is, has the CDC changed it's public human health risk assessment? 🤔 In short, no, it hasn't. The CDC stresses that these cases are sporadic. Although individuals who are frequently exposed to infected or potentially infected animals should be taking extra precautions 🧤😷, the CDC's assessment of the general public's health risk remains low. Read more about this breaking news in the CDC's newsroom release 📰: https://lnkd.in/evFQzv_K For more breaking news, subscribe to our monthly 📅 newsletter: https://rb.gy/isydg 🧠
-
It's #FunFactFriday 🤓 Did you know that as of March 31st, 2024, 7 countries generate 99.7% of their electric energy ⚡ from renewable sources ♻️🤯?!? These seven countries are Albania, Bhutan, Nepal, Paraguay, Iceland, Ethiopia and the Democratic Republic of Congo. On top of this, another 40 countries produced at least 50% of their electricity from renewable sources such as wind💨, water🌊, solar☀️, and geothermal🌋 energies. That's a whole lot of renewable energy! 🌎 Click the link below to learn more about who's using renewable energy: https://lnkd.in/drESySC8 #renewablepower #technology #funfact #Progress #Global
-
From the scientific journal Nature: "Millions of people died of COVID-19 because the fundamental principle of equity between nations was ignored during the outbreak. That must not be allowed to happen again" Read the full article here: https://lnkd.in/epZDwRhU
-
📰🚨 Newsletter Alert! 📰🚨 Ever wondered how we got from the discovery 🔍 of lentiviruses as a viral genus to lentiviral gene therapy 🧬📦? This month, we're delving into the Science of Lentiviruses. From their discovery all the way to the third generation of lentiviral vectors, our May newsletter is going to talk about everything Lentivirus 🦠! To pique your interest 🧐, we've highlighted several fun facts from the newsletter: 1. The first lentiviral vector use as a tool for gene therapy was derived from the notorious human immunodeficiency virus (HIV) 🦠 2. Some lentiviruses have incubation periods of months or even years 🤯 3. In 1843 in France, what would later be called Equine Infectious Anemia (EIA) ravaged horses and became the first recorded lentiviral outbreak 🐎 4. Lentiviruses are able to permanently incorporate transgenes into host cells - making them ideal gene therapy candidates 🧬 5. Lentiviruses can infect infect both dividing and non-dividing cells - again making them ideal gene therapy candidates 🧫 6. A scientists named Didier Trono is credited with the idea of creating a vector for gene delivery using the lentivirus HIV-1 👨🔬 7. To date, there exist three lentiviral packaging systems - with the third being the safest and most efficient system yet 📦 8. The United States Food and Drug Administration (FDA) has approved of about a dozen lentiviral gene therapies - and more approvals are surely not far behind 📃 To get the full scoop🥄, read our Science of Lentiviruses Newsletter here: https://conta.cc/4aH0naq For more interesting biotech facts and news, subscribe to our monthly newsletter: https://rb.gy/isydg 🧠 #lentivirus #biotech #history
-
🔬 Pioneering Biomedical Solutions: IBT Bioservices' Fight Against Filoviruses IBT Bioservices leads the charge against Hemorrhagic Fever Viruses, including Filoviruses like Ebola, Sudan, and Marburg viruses, with tailored reagents and services designed to combat these lethal pathogens. For over 15 years, our team has been at the forefront of infectious disease research, specializing in preclinical testing to evaluate novel therapies and strategies against some of the world's deadliest viruses. Filovirus research presents unique challenges, notably the need for high containment laboratories, which can escalate costs and prolong therapeutic development timelines. However, our expert scientists have developed innovative solutions to accelerate progress. Key to our approach is the use of surrogate pseudotype models, replicating authentic filoviruses under controlled conditions. This enables us to conduct significant preclinical testing within biosafety level 2 (BSL-2) facilities, ensuring both efficiency and safety. Beyond the lab, we provide comprehensive support to researchers worldwide, offering a diverse range of high-quality research use reagents such as monoclonal antibodies, ELISA kits, glycoproteins and viral proteins tailored to support their filovirus research. By fostering collaboration and innovation, IBT Bioservices continues to lead the way in biomedical research, working tirelessly towards a world free from the threat of infectious diseases. Visit our website for more information or get in touch with one of our team members directly! Website: https://lnkd.in/eY6Kd9vs Email: [email protected] #BiomedicalInnovation #FilovirusResearch #PreclinicalTesting #EbolaResearch #IBTBioservices
-
-
It's #FunFactFriday 🤓 #DidYouKnow that viruses evolve faster than any other organism!? 🦠💨🦠Scientists believe that this fact coupled with viruses' short replication times ⏰ and large population size make them so dangerous ⚠️ to humans and other species. Want to learn more? Our #newsletter is releasing early next week! 📆 Sign up to get the full scoop at https://rb.gy/isydg 🥄 #FunFact #virology #evolution #science
-
If you're a visual learner like a few of us here at Virongy Biosciences, Inc. 👀✋, a video protocol is just what the doctor ordered. In this one, we show you how to use our rapid Hybrid-Alpha Pseudovirus (Ha-PV) system 🦠 to run a neutralization assay. Ha-PV serves as a platform for quick, easy, and reliable quantification of neutralizing antibodies, viral variants, and antiviral drugs 💊 More helpful videos like this one can also be found on our YouTube page! https://lnkd.in/ekBNXzX4 Learn more about our HA-PV system on our website: https://lnkd.in/eSCWsTGe
Virongy Neutralization Assay Kit - Protocol
https://www.youtube.com/